Finding New Therapy Targets for Mast Cell Tumors
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.
Researchers will identify new therapy targets for malignant mast cell tumors, acommon and aggressive cancer in dogs.
Researchers will investigate how metabolic processes affect tumor growth andchemotherapy resistance in dogs with hemangiosarcoma and ways to block or disrupt these processes.
Researchers will investigate an economical, rapid-imaging method to see if cancer cells are left behind following surgical removal of sarcomas in cats.
Researchers are evaluating the effectiveness of oral rapamycin as an adjunct, postsurgery therapy to combat cancer spread (metastasis) in client-owned dogs.
Researchers are studying a group of 80 dogs with osteosarcoma to generate comparison data for ongoing and future studies of new chemotherapeutic agents.
Researchers will investigate a novel therapeutic target for mammary gland cancer in dogs.
Researchers will assess the value of a genetic prognostic tool to assist with treatment decisions for dogs with diffuse large B-cell lymphoma.